Vital Signs Monitoring Devices Market Worth $66.82 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners

Global vital signs monitoring devices market is growing at a CAGR of 12.7% from 2022 to 2030.


Pune, India, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Vital signs monitoring devices measure basic medical conditions such as pulse, temperature, blood pressure, and breathing. The devices include thermometers, pulse oximeters, blood pressure monitors, and glucose monitors used to detect and monitor vital conditions in different medical or healthcare settings such as hospitals, ambulatory surgical centers, home care settings, and others.

According to our new research study on “Vital Signs Monitoring Devices Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Pulse Oximeters, Blood Pressure Monitors, Temperature Monitoring Devices, and Glucose Monitoring Devices), End User (Hospitals and Clinics, Ambulatory Care Centers, Home Healthcare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America),” the global vital signs monitoring devices market size was valued at $25.61 billion in 2022 and is expected to reach $66.82 billion by 2030. It is estimated to grow at a CAGR of 12.7% from 2022 to 2030.


Download Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPHE100001258


Global Vital Signs Monitoring Devices Market – Report Scope:

Report CoverageDetails
Market Size Value inUSD 25.61 Billion in 2022
Market Size Value byUSD 66.82 Billion by 2030
Growth rateCAGR of 12.7% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
No. of Pages223
No. of Tables167
No. of Charts & Figures68
Historical data availableYes
Segments coveredProduct, End User, and Geography


Global Vital Signs Monitoring Devices Market: Competitive Landscape and Key Developments
Koninklijke Philips NV, Medtronic Plc, Nihon Kohden Corp, GE HealthCare Technologies Inc, OMRON Corp, Nonin Medical Inc, SunTech Medical Inc, Masimo Corp, Contec Medical Systems Co Ltd, and Baxter International Inc. are among the leading companies operating in the vital signs monitoring devices market. These players focus on expanding and diversifying their market presence, and acquiring a novel customer base, thereby tapping prevailing business opportunities in the vital signs monitoring devices market. A few of the major introduced into the vital signs monitoring devices market are as follows.

In June 2023, Masimo got 510(k) clearance from the US Food and Drug Administration (FDA) for its patient-worn, continuous multi-parameter vital signs monitor called Radius VSM. Developed using a modular platform, Radius VSM enables clinicians to monitor several physiological measurements such as Masimo SET pulse oximetry, temperature, respiration rate, electrocardiography, and noninvasive blood pressure evaluation.

In June 2022, GE Healthcare introduced the Portrait Mobile, a wireless vital sign monitoring system that allows continuous monitoring throughout a patient’s hospital stay. The system helps clinicians detect the deterioration of a patient’s condition. Early knowledge of health deterioration can help reduce the length of stay and instances of ICU admissions, ultimately improving patient outcomes.

In February 2021, SunTech Medical Inc. and Valencell Inc. announced a proof of concept for DeltaTrak technology. The patent-pending innovation combines the gold-standard accuracy and superior motion tolerance capabilities of SunTech’s Advantage cuff-based BP monitoring device with a continuous interpolative BP monitoring capability that continuously interpolate BP monitoring from Valencell’s optical PPG (photoplethysmography) technology between two cuff readings.


Use of Radar Technology in Healthcare Would Lead to Future Trends in Market:
Radar technologies have been studied for decades for their applications in healthcare. The advantages of radar technologies have led to increased interest among researchers, and enabled the development of continuous contactless heart and respiration rate monitoring devices. Contactless monitoring would reduce the risk of cross-infection among patients and healthcare professionals, in addition to assisting doctors in accurate diagnoses. Compactness, discreetness, anonymity, robustness, and energy efficiency are the key advantages of radar technologies.

Government agencies and companies have been working on projects focused on using radar technologies in devices and enhance the quality of patients. In January 2017, the German Federal Ministry of Education and Research (BMBF) initiated the GUARDIAN research project (stands for GUarded by Advanced Radar technology-based DIagnostics applied in palliative and intensive care Nursing) to accelerate intensive and palliative care innovations. Out of the US$ 2.33 million (2.46 million euros) of investment raised for this project, the BMBF accounted for a 60% share. In November 2020, the project was successfully concluded, and in February 2021, BMBF shared details about the GUARDIAN research project. Under the project, an innovative, contactless radar sensor was developed to monitor vital signs. The sensor was developed in collaboration between the Friedrich–Alexander University Erlangen–Nürnberg, InnoSenT (a radar technology company), the University Hospital of Erlangen, Geratherm Respiratory GmbH, Wilhelm Löhe Hochschule – Wissenschaft (a university of applied sciences), Forschung WuF GmbH, and the Brandenburg University of Technology Cottbus-Senftenberg. These institutes and companies have significantly researched and analyzed the integration of radar technology into the patient monitoring workflow. The innovative sensors are now available in a few healthcare systems to enhance diagnostics with distance resolution and signal processing. Thus, the integration of radar technologies is expected to emerge as a promising trend in the vital signs monitoring devices market during the forecast period.


Order a Copy of this Report at https://www.theinsightpartners.com/buy/TIPHE100001258


Global Vital Signs Monitoring Devices Market: Segmental Overview
The vital signs monitoring devices market has been segmented on the basis of product, end user, and geography. The market, by product, is segmented into pulse oximeters, temperature monitoring devices, glucose monitoring devices, and blood pressure monitors. In 2022, the glucose monitors segment held the largest market share, and the pulse oximeters segment is expected to record the fastest CAGR during 2022–2030.

Based on end user, the vital signs monitoring devices market is categorized into hospitals and clinics, ambulatory care centers, home healthcare, and others. The hospitals and clinics segment held the largest market share in 2022. The home healthcare segment is estimated to register the fastest CAGR during 2022–2030.


Go through further research published by The Insight Partners:

Vital Signs Equipment Market - Global Analysis and Forecast to 2030

Vital Sign OEM Modules Market - Global Analysis and Forecast to 2030

Medical Device Connectivity Market - Global Analysis and Forecast to 2028


About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com    
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/vital-signs-monitoring-devices-market